Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1972 1
1978 1
1979 1
1981 1
1982 1
1983 3
1984 2
1985 2
1987 3
1988 3
1990 2
1991 2
1992 1
1993 2
1994 1
1996 3
1997 3
1998 2
1999 10
2000 12
2001 14
2002 11
2003 8
2004 15
2005 13
2006 14
2007 15
2008 21
2009 21
2010 12
2011 16
2012 16
2013 14
2014 15
2015 17
2016 6
2017 6
2018 3
2019 7
2020 13
2021 10
Text availability
Article attribute
Article type
Publication date

Search Results

295 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2.
Lipton RB, Goadsby PJ, Smith J, Schaeffler BA, Biondi DM, Hirman J, Pederson S, Allan B, Cady R. Lipton RB, et al. Among authors: cady r. Neurology. 2020 Mar 31;94(13):e1365-e1377. doi: 10.1212/WNL.0000000000009169. Epub 2020 Mar 24. Neurology. 2020. PMID: 32209650 Free PMC article. Clinical Trial.
Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy-2) study.
Silberstein S, Diamond M, Hindiyeh NA, Biondi DM, Cady R, Hirman J, Allan B, Pederson S, Schaeffler B, Smith J. Silberstein S, et al. Among authors: cady r. J Headache Pain. 2020 Oct 6;21(1):120. doi: 10.1186/s10194-020-01186-3. J Headache Pain. 2020. PMID: 33023473 Free PMC article. Clinical Trial.
295 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page